
Verrica Receives Complete Response Letter from the FDA
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration (FDA) this week issued a Complete Response Letter (CRL) regarding its New …
Verrica Receives Complete Response Letter from the FDA Read More